SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
30 Aug 2019
Historique:
received: 05 03 2019
revised: 13 06 2019
accepted: 17 06 2019
pubmed: 21 6 2019
medline: 30 7 2019
entrez: 21 6 2019
Statut: ppublish

Résumé

The pathogenesis of endometrial cancer (EC) involves many regulatory pathways including transcriptional regulatory networks supported by transcription factors and microRNAs only in part known. The aim of this retrospective study was to explore the possible correlation in the EC microenvironment between master regulators of complex phenomena such as steroid responsiveness through estrogen receptor alpha (ERα) and progesterone receptor (PR), epithelial-to-mesenchymal transition (supported by SLUG transcription factor), hypoxia (with hypoxia inducible factor-1 alpha, HIF-1α), and obesity that has been recognized as a EC risk factor. Formalin-Fixed Paraffin-Embedded (FFPE) blocks from University of Ferrara Pathology Archive were used and allocated into 2 groups according to their immunohistochemical positivity to ERα and PR, distinguishing the samples with a more benign prognosis (ERα We showed a comparable percentage of HIF1-α and SLUG positive samples in the ERα A molecular circuit of mutual regulation between ERα, PR, HIF1-α, SLUG and miR-221 is feasible in the EC and was firstly suggested by our research. In this interplay miR-221 seems to be in a nodal point of the regulatory system that is particularly strengthened by the metabolic changes in obesity.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
The pathogenesis of endometrial cancer (EC) involves many regulatory pathways including transcriptional regulatory networks supported by transcription factors and microRNAs only in part known. The aim of this retrospective study was to explore the possible correlation in the EC microenvironment between master regulators of complex phenomena such as steroid responsiveness through estrogen receptor alpha (ERα) and progesterone receptor (PR), epithelial-to-mesenchymal transition (supported by SLUG transcription factor), hypoxia (with hypoxia inducible factor-1 alpha, HIF-1α), and obesity that has been recognized as a EC risk factor.
METHODS METHODS
Formalin-Fixed Paraffin-Embedded (FFPE) blocks from University of Ferrara Pathology Archive were used and allocated into 2 groups according to their immunohistochemical positivity to ERα and PR, distinguishing the samples with a more benign prognosis (ERα
RESULTS RESULTS
We showed a comparable percentage of HIF1-α and SLUG positive samples in the ERα
CONCLUSIONS CONCLUSIONS
A molecular circuit of mutual regulation between ERα, PR, HIF1-α, SLUG and miR-221 is feasible in the EC and was firstly suggested by our research. In this interplay miR-221 seems to be in a nodal point of the regulatory system that is particularly strengthened by the metabolic changes in obesity.

Identifiants

pubmed: 31220580
pii: S0378-1119(19)30588-8
doi: 10.1016/j.gene.2019.06.028
pii:
doi:

Substances chimiques

ESR1 protein, human 0
Estrogen Receptor alpha 0
HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
MIRN221 microRNA, human 0
MicroRNAs 0
Receptors, Progesterone 0
SNAI1 protein, human 0
Snail Family Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Pagination

143938

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Letizia Penolazzi (L)

Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy.

Gloria Bonaccorsi (G)

Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Roberta Gafà (R)

Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Noemi Ravaioli (N)

Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Deborah Gabriele (D)

Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Cristina Bosi (C)

Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Giovanni Lanza (G)

Department of Medical Sciences, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Pantaleo Greco (P)

Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, S. Anna University Hospital, Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.

Roberta Piva (R)

Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy. Electronic address: piv@unife.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH